NanoViricides
NNVC
#10132
Rank
C$30.58 M
Marketcap
C$1.70
Share price
0.82%
Change (1 day)
-16.99%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of June 2025 : C$2.15 Million

According to NanoViricides's latest financial reports the company has C$2.15 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30C$6.55 M-39.18%
2023-06-30C$10.78 M-40.44%
2022-06-30C$18.1 M-28.78%
2021-06-30C$25.42 M36.64%
2020-06-30C$18.6 M456.32%
2019-06-30C$3.34 M-64.08%
2018-06-30C$9.31 M-52.53%
2017-06-30C$19.61 M-37.35%
2016-06-30C$31.3 M-20.26%
2015-06-30C$39.26 M0.26%
2014-06-30C$39.15 M167.52%
2013-06-30C$14.63 M0.71%
2012-06-30C$14.53 M63.49%
2011-06-30C$8.89 M20.73%
2010-06-30C$7.36 M279.35%
2009-06-30C$1.94 M133.42%
2008-06-30C$0.83 M-18.94%
2007-06-30C$1.02 M-63.15%
2006-06-30C$2.78 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
BioCryst Pharmaceuticals
BCRX
C$0.29 B 13,558.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.05 B 48,848.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.15 B 471,425.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$22.79 B 1,058,697.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$25.16 B 1,168,542.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$6.13 B 285,059.38%๐Ÿ‡ฌ๐Ÿ‡ง UK